Showing results (651-660 of 735) with videos related to
Sort By:
Pageof 74
Nature Medicine|June 5, 2020
Publisher Correction: Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancerKroopa Joshi, Marc Robert de Massy, Mazlina Ismail, et al.Nature Medicine|October 9, 2019
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancerKroopa Joshi, Marc Robert de Massy, Mazlina Ismail, et al.Plos One|March 21, 2024
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination historyHermaleigh Townsley, Joshua Gahir, Timothy W Russell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2024
Outcomes With Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma in CheckMate 238Jeffrey Weber, Michele Del Vecchio, Mario Mandalá, et al.European Journal of Cancer (Oxford, England : 1990)|August 14, 2022
Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteriaJames Larkin, Jeffrey Weber, Michele Del Vecchio, et al.The Lancet. Oncology|September 22, 2020
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trialPaolo A Ascierto, Michele Del Vecchio, Mario Mandalá, et al.The Lancet. Oncology|March 22, 2015
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trialJeffrey S Weber, Sandra P D'Angelo, David Minor, et al.Nature|December 21, 2017
Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolutionChristopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, et al.Cancer Cell|July 4, 2025
Subclonal immune evasion in non-small cell lung cancerKrijn K Dijkstra, Roberto Vendramin, Despoina Karagianni, et al.Science Translational Medicine|July 2, 2025
A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasisShawn C Chafe, Kui Zhai, Nikoo Aghaei, et al.Pageof 74